Olanzapine is indicated for the treatment of a moderate to severe manic episode. In bipolar patients with a manic episode that has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence. Brand name: Zyprexa. Regulatory status: In France, olanzapine is not registered for bipolar disorder. Launch date: Not available.
